David Bearden, Pharm.D., has been appointed as Dean, Oregon State University College of Pharmacy. In his role as Dean, Bearden will be the chief administrative officer for the college that includes faculty, staff, and students based both at OSU’s main campus in Corvallis, and the Oregon Health & Science University campus in Portland. This position provides overall leadership for the College’s academic, research, and outreach programs, stewards its financial resources, and serves as its principal representative with internal and external stakeholders.
Bearden previously served as Interim Dean of the College of Pharmacy from December 2020, and has held key roles at the college over the last two decades, including Associate Dean of Academic Integration and Clinical Advancement based at the college’s Portland location, and chair of the Department of Pharmacy Practice.
Through a long-standing partnership, OSU and OHSU jointly award the Doctor of Pharmacy degree, and the College of Pharmacy is an important partner to OHSU with multiple academic, research, and clinical connections anchored within the shared collaborative RLSB space. The College of Pharmacy, which is based in both Corvallis and Portland, has approximately 70 faculty and staff, enrolls just over 300 students, and has upward of 5,000 alumni. Last fiscal year, it received more than $8 million in research funding.
As a clinical faculty member, Bearden has been a practicing pharmacist and previously served as an inpatient clinical specialist in infectious diseases pharmacotherapy at OHSU and Portland Veterans Affairs Medical Center. He is a Fellow by the American College of Clinical Pharmacy and the Society of Infectious Diseases Pharmacists, a recipient of the OHSU Faculty Senate Outstanding Leadership Award, and an awardee of several teaching and precepting honors by multiple Pharmacy classes.
Bearden’s Doctor of Pharmacy is from the University of Illinois at Chicago. He completed a PGY-1 residency at the University of Utah Hospitals and Clinics, and a fellowship in infectious diseases pharmacotherapy at the University of Illinois at Chicago.